|Videos|July 27, 2021

Pharmaceutical CEO Leadership: Collaboration in Pharma – Working Together

In this segment, members of the Pharmaceutical CEO Leadership: Collaboration in Pharma panel comment on the various types of collaboration within the industry. They also discuss how working with FDA helped streamline the drug development process through the pandemic and highlight additional lessons the industry could learn from collaborative efforts during COVID.


Related to this article

Former U.S. Representative Joe Cunningham (D-SC), spokesperson, Pharmaceutical Reform Alliance.
Former U.S. Representative Joe Cunningham (D-SC), spokesperson, Pharmaceutical Reform Alliance. dismisses the pharmaceutical industry's innovation argument against MFN pricing.
Joe Cunningham (D-SC) and spokesperson for the Pharmaceutical Reform Alliance,
Joe Cunningham argues that the most-favored-nation drug pricing agreements carry no legislative weight and discusses what the program actually locks in.